Skip to main content
Livermore
Livermore
ZHEN

Stratos Wealth Advisors, LLC

SEC CIK
0001707202
Latest filing
Aug 11, 2026

REGN holding history

Regeneron Pharmaceuticals, Inc. in every 13F filed by Stratos Wealth Advisors, LLC, including the quarters it was sold out or no filing was made. Changes compare share counts with the previous calendar quarter.

REGN overviewAll 13F holders of REGNFull Q2 2026 holdings

Shares (Q2 2026)
8,630
Value
$5.38M
% of portfolio
0.3%
Quarters held
21
Since Q1 2021
Holdings of REGN by Stratos Wealth Advisors, LLC, by quarter
QuarterSharesValue% of portfolioShare changeActionAll holders
Q2 20268,630$5.38M0.3%−65−0.7%ReducedHolders
Q1 20268,695$6.72M0.4%+222+2.6%AddedHolders
Q4 20258,473$6.54M0.3%+481+6.0%AddedHolders
Q3 20257,992$4.49M0.2%−52−0.6%ReducedHolders
Q2 20258,044$4.22M0.2%−183−2.2%ReducedHolders
Q1 20258,227$5.22M0.3%−354−4.1%ReducedHolders
Q4 20248,581$6.11M0.3%−67−0.8%ReducedHolders
Q3 20248,648$9.09M0.4%−30−0.3%ReducedHolders
Q2 20248,678$9.12M0.5%+213+2.5%AddedHolders
Q1 20248,465$8.15M0.5%+156+1.9%AddedHolders
Q4 20238,309$7.30M0.4%00.0%UnchangedHolders
Q3 20238,309$6.84M0.5%+266+3.3%AddedHolders
Q2 20238,043$5.78M0.4%+180+2.3%AddedHolders
Q1 20237,863$6.46M0.5%+800+11.3%AddedHolders
Q4 20227,063$5.10M0.4%+4,781+209.5%AddedHolders
Q3 20222,282$1.57M0.2%+322+16.4%AddedHolders
Q2 20221,960$1.16M0.1%+725+58.7%AddedHolders
Q1 20221,235$863.0K0.1%−759−38.1%ReducedHolders
Q4 20211,994$1.26M0.1%+325+19.5%AddedHolders
Q3 20211,669$1.01M0.1%+1,669NewHolders
Q2 20210$00.0%−576−100.0%Sold outHolders
Q1 2021576$273.0K<0.1%––Holders

Livermore's 13F data starts with Q1 2021, so Q1 2021 has no change from the previous quarter.